Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study

Invest New Drugs. 1991 Nov;9(4):373-4. doi: 10.1007/BF00183585.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / adverse effects
  • Azacitidine / therapeutic use*
  • Drug Evaluation
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged

Substances

  • Antineoplastic Agents
  • fazarabine
  • Azacitidine